A Breakthrough in Prime Editing That Could Transform Treatment for Numerous Rare Diseases

This week, researchers at the Broad Institute of MIT and Harvard unveiled a groundbreaking advancement in genetic medicine: a novel prime-editing platform known as Prime-Editing-Based Read-Through (PERT). This innovative system has the potential to address a wide array of genetic mutations through a single, versatile strategy, offering significant hope for patients and researchers tackling rare…